# ROPIVACAINE HYDROCHLORIDE
> **ANDA219883** · Abbreviated New Drug Application (Generic) · Sponsor: ANTHEA PHARMA · Approved 2025-03-21
## Drug
- **FDA Application Number:** ANDA219883
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROPIVACAINE HYDROCHLORIDE
- **Generic name:** ROPIVACAINE HYDROCHLORIDE
- **Active ingredients:** ROPIVACAINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ANTHEA PHARMA
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2025-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219883)
---
*AI Analytics · CC0 1.0*